Reading Time: < 1 minuteAs we’ve mentioned in previous posts, our current research grants round is our biggest yet with 19 full applications being reviewed by our research advisory
Reading Time: 2 minutesForm filling is tedious. For those of us of a certain age (I’m not saying any more!) online form filling is even more stressful. So recently,
Reading Time: 2 minutesAn unproven treatment called ‘Spirulina’, which is a type of blue-green algae, has recently been investigated by ALSUntangled*. They concluded that there is no evidence
Reading Time: 3 minutesA study led by MND Association funded researcher Prof Siddharthan Chandran from the University of Edinburgh has developed a new method to create a diverse group
Reading Time: 2 minutesYesterday we heard that a new study had been published in the Archives of Neurology reporting that people who had (ever) smoked were 1.4 times
Reading Time: < 1 minuteBack in spring 2009 I took part in an awareness raising event organised by the drug company GlaxoSmithKline (GSK). The company was starting to make
Reading Time: 2 minutesIt was then back to the science. Prof Frank Soldner (Massachusetts Institute of Technology) provided an overview of a new and exciting way in which
Reading Time: 2 minutesThe room was crowded at 8am for the first presentation of day two, from Dr Doug Sipp (RIKEN Institute, Japan) on ‘Unregulated ALS/MND treatments and public education’. Dr
Reading Time: 2 minutesOne human neural stem cell line that has cleared the US Government’s regulatory hurdles is that developed by the biotechnology company Neuralstem. To date, nine
Reading Time: 2 minutesThe remainder of the morning covered some of the preclinical research that has laid the foundations for current and forthcoming clinicalstudies. Prof Clive Svendsen, from University Wisconsin-Madison, gave an